Ramucirumab Extends Gastric Cancer Survival

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2014-022
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Combo Therapy for Lung Cancer Extends Survival

Cancer Discovery
Oncology
2018English

Gastric Perforation Related to Concurrent Use of Nintedanib and Ramucirumab

Respirology Case Reports
PulmonaryRespiratory Medicine
2018English

GM-CSF/Ipilimumab Combination Extends Melanoma Survival

Cancer Discovery
Oncology
2013English

Ramucirumab Combined With Paclitaxel as the Second-Line Chemotherapy for Elderly Patients With Disseminated Gastric Cancer

Medical Council
2018English

Socioeconomic Status and Gastric Cancer Survival in Japan

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2010English

Predictive Model for Survival in Patients With Gastric Cancer

Acta Healthmedica
2017English

Metabolic Syndrome, Gastric Cancer Mortality and Competing Risk Survival Analysis

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy